Michelle Cunningham

Michelle Cunningham has a diverse work experience spanning multiple industries and roles. Michelle is currently working as an Associate Director, Key Accounts at TG Therapeutics, Inc. since October 2022. Prior to that, Michelle founded a stealthmode start-up in 2022.

Before their entrepreneurial endeavor, they worked at Biogen as an Executive Territory Business Manager in the Alzheimer's Division from 2020 to 2022. Michelle also had a role as the West Divisional Field Trainer at Biogen in 2018.

Michelle's earlier experience includes a position at Novotech as Business Development USA from 2019 to 2020. Michelle worked at Biogen for a significant portion of their career, starting as an Executive Territory Business Manager in 2007 and holding that role until 2019. In 2018, they also served as a West Divisional Field Trainer at Biogen.

Prior to their time at Biogen, they held various sales and executive roles at companies such as Medtronic, Cyberonics, Cytometrics, Takeda Pharmaceuticals, and Johnson & Johnson.

Overall, Michelle Cunningham has a strong background in sales, business development, and territory management in the pharmaceutical and medical device industries.

Michelle Cunningham is currently enrolled in the Wondry-Sullivan Family Ideator & Builder Program at Vanderbilt University, where they are pursuing a degree in Innovation & Entrepreneurship. Prior to their enrollment at Vanderbilt, Michelle attended Belmont University, Middle Tennessee State University (MTSU), and Volunteer State Community College, where they focused on Nursing. However, it is not specified whether they completed a degree at any of these institutions.